Celldex Therapeutics, Inc. Contracts & Agreements

Sales Agreement, dated February 26, 2024, by and between Celldex Therapeutics, Inc. and Cantor Fitzgerald & Co (Filed With SEC on February 26, 2024)

Underwriting Agreement, dated November 7, 2023, by and among Celldex Therapeutics, Inc. and Jefferies LLC and Leerink Partners LLC, as representatives of the several underwriters... (Filed With SEC on November 8, 2023)

Celldex Therapeutics, Inc. 2021 Omnibus Equity Incentive Plan (as amended June 15, 2023) (Filed With SEC on June 15, 2023)

Description of Securities (Filed With SEC on February 28, 2023)

Amended and Restated License Agreement by and between the Company and Yale University dated as of July 26, 2022 (Filed With SEC on November 9, 2022)

Tenth Amendment to Lease by and between the Company and University of Massachusetts Dartmouth dated as of August 1, 2022 (Filed With SEC on November 9, 2022)

Third Amendment to Lease Agreement between the Company and Perryville SPE LLC (successor-in-interest) to Crown Perryville, LLC dated as of May 23, 2022 (Filed With SEC on August 8, 2022)

Confidential Settlement Agreement and Mutual Release, dated July 15, 2022 by and between Shareholder Representatives Services LLC, solely in its capacity as Stockholders... (Filed With SEC on July 18, 2022)

Binding Settlement Term Sheet, dated June 20, 2022 by and between Shareholder Representatives Services LLC, solely in its capacity as Stockholders Representative, and Celldex... (Filed With SEC on June 23, 2022)

Underwriting Agreement, dated July 13, 2021, by and between Celldex Therapeutics, Inc. and Jefferies LLC and SVB Leerink LLC, as representatives of the underwriters named therein (Filed With SEC on July 14, 2021)

Amended and Restated Employment Agreement, dated as of July 1, 2021, by and between Celldex Therapeutics, Inc. and Anthony S. Marucci (Filed With SEC on July 1, 2021)

Amended and Restated Employment Agreement, dated as of July 1, 2021, by and between Celldex Therapeutics, Inc. and Sam Martin (Filed With SEC on July 1, 2021)

Amended and Restated Employment Agreement, dated as of July 1, 2021, by and between Celldex Therapeutics, Inc. and Tibor Keler, Ph.D (Filed With SEC on July 1, 2021)

Amended and Restated Employment Agreement, dated as of July 1, 2021, by and between Celldex Therapeutics, Inc. and Ronald Pepin, Ph.D (Filed With SEC on July 1, 2021)

Amended and Restated Employment Agreement, dated as of July 1, 2021, by and between Celldex Therapeutics, Inc. and Sarah Cavanaugh (Filed With SEC on July 1, 2021)

Amended and Restated Employment Agreement, dated as of July 1, 2021, by and between Celldex Therapeutics, Inc. and Margo Heath-Chiozzi, M.D (Filed With SEC on July 1, 2021)

Amended and Restated Employment Agreement, dated as of July 1, 2021, by and between Celldex Therapeutics, Inc. and Elizabeth Crowley (Filed With SEC on July 1, 2021)

Amended and Restated Employment Agreement, dated as of July 1, 2021, by and between Celldex Therapeutics, Inc. and Richard Wright, Ph.D (Filed With SEC on July 1, 2021)

Amended and Restated Employment Agreement, dated as of July 1, 2021, by and between Celldex Therapeutics, Inc. and Diane Young, M.D (Filed With SEC on July 1, 2021)

Amended and Restated Employment Agreement, dated as of July 1, 2021, by and between Celldex Therapeutics, Inc. and Freddy Jimenez (Filed With SEC on July 1, 2021)

Celldex Therapeutics, Inc. 2021 Omnibus Equity Incentive Plan (Filed With SEC on June 17, 2021)

Celldex Therapeutics, Inc. Form of Restricted Stock Award Agreement (Filed With SEC on June 17, 2021)

Celldex Therapeutics, Inc. Form of Incentive Stock Option Grant Agreement (Filed With SEC on June 17, 2021)

Celldex Therapeutics, Inc. Form of Nonqualified Stock Option Grant Agreement (Filed With SEC on June 17, 2021)

Celldex Therapeutics, Inc. Form of Restricted Stock Unit Award Agreement (Filed With SEC on June 17, 2021)

Employment Agreement, dated as of January 1, 2021, by and between Freddy Jimenez and Celldex Therapeutics., Inc (Filed With SEC on January 4, 2021)

Extension of Lease Agreement between the Company and University of Massachusetts Dartmouth dated as of July 1, 2020 (Filed With SEC on August 6, 2020)

Celldex Therapeutics, Inc. Amended and Restated 2008 Stock Option and Incentive Plan (as amended, effective June 18, 2020) (Filed With SEC on June 18, 2020)

Underwriting Agreement, dated June 15, 2020 (Filed With SEC on June 17, 2020)

DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 (Filed With SEC on March 26, 2020)

Ninth Amendment to Lease by and between the Company and University of Massachusetts Dartmouth dated as of October 1, 2019 (Filed With SEC on March 26, 2020)

Employment Agreement, dated as of July 8, 2019, by and between Diane Young and Celldex Therapeutics., Inc (Filed With SEC on June 24, 2019)

Celldex Therapeutics, Inc. Amended and Restated 2008 Stock Option and Incentive Plan (as amended, effective as of June 19, 2019) (Filed With SEC on June 20, 2019)

Celldex Therapeutics, Inc. Amended and Restated 2004 Employee Stock Purchase Plan (effective as of June 19, 2019) (Filed With SEC on June 20, 2019)

Second Amendment to Lease Agreement between the Company and Crown Perryville, LLC dated as of March 8, 2019 (Filed With SEC on May 7, 2019)

Specimen of Common Stock Certificate (Filed With SEC on February 8, 2019)

Form of Non-Employee Director Stock Option Agreement (Filed With SEC on August 8, 2018)

License and Option Agreement by and between MedImmune, LLC and the Company, dated July 24, 2013, as amended by the Amendment, dated October 27, 2015 (Filed With SEC on March 7, 2018)

Third Amended and Restated License Agreement by and between Yale University and the Company, dated March 14, 2013, as amended by the Amendments, dated March 21, 2014 and December... (Filed With SEC on March 7, 2018)

2008 Stock Option and Incentive Plan, as amended and restated (Filed With SEC on March 7, 2018)

2004 Employee Stock Purchase Plan, as amended and restated (Filed With SEC on March 7, 2018)

Amended and Restated Employment Agreement, dated as of January 1, 2018, by and between Celldex Therapeutics, Inc. and Anthony S. Marucci (Filed With SEC on December 29, 2017)

Amended and Restated Employment Agreement, dated as of January 1, 2018, by and between Celldex Therapeutics, Inc. and Sam Martin (Filed With SEC on December 29, 2017)

Amended and Restated Employment Agreement, dated as of January 1, 2018, by and between Celldex Therapeutics, Inc. and Tibor Keler, Ph.D (Filed With SEC on December 29, 2017)

Amended and Restated Employment Agreement, dated as of January 1, 2018, by and between Celldex Therapeutics, Inc. and Ronald Pepin, Ph.D (Filed With SEC on December 29, 2017)

Amended and Restated Employment Agreement, dated as of January 1, 2018, by and between Celldex Therapeutics, Inc. and Sarah Cavanaugh (Filed With SEC on December 29, 2017)

Amended and Restated Employment Agreement, dated as of January 1, 2018, by and between Celldex Therapeutics, Inc. and Margo Heath-Chiozzi, M.D (Filed With SEC on December 29, 2017)

Amended and Restated Employment Agreement, dated as of January 1, 2018, by and between Celldex Therapeutics, Inc. and Elizabeth Crowley (Filed With SEC on December 29, 2017)

Amended and Restated Employment Agreement, dated as of January 1, 2018, by and between Celldex Therapeutics, Inc. and Richard Wright, Ph.D (Filed With SEC on December 29, 2017)

Employment Agreement, dated as of October 3, 2017, by and between Margo Heath-Chiozzi and Celldex Therapeutics., Inc (Filed With SEC on October 3, 2017)

EMPLOYMENT AGREEMENT (Filed With SEC on July 5, 2017)

EMPLOYMENT AGREEMENT (Filed With SEC on June 16, 2017)

EMPLOYMENT AGREEMENT (Filed With SEC on December 5, 2016)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on August 11, 2016)

CELLDEX THERAPEUTICS, INC. Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on May 19, 2016)

SECOND AMENDMENT TO LEASE (Filed With SEC on February 23, 2016)

EIGHTH AMENDMENT TO LEASE (Filed With SEC on February 23, 2016)

FIRST AMENDMENT OF LEASE (Filed With SEC on August 10, 2015)

EMPLOYMENT AGREEMENT (Filed With SEC on August 10, 2015)

CELLDEX THERAPEUTICS, INC. 2008 STOCK OPTION AND INCENTIVE PLAN as amended and restated effective as of June 10, 2015 (Filed With SEC on June 11, 2015)

7,250,000 Shares Celldex Therapeutics, Inc. Common Stock, $0.001 Par Value per Share UNDERWRITING AGREEMENT (Filed With SEC on February 26, 2015)

THIRD AMENDED AND RESTATED SUPPLY AGREEMENT (Filed With SEC on November 5, 2014)

CELLDEX THERAPEUTICS, INC. SUBSCRIPTION AGREEMENT (Filed With SEC on October 20, 2014)

7,000,000 Shares Celldex Therapeutics, Inc. Common Stock, $0.001 Par Value per Share UNDERWRITING AGREEMENT (Filed With SEC on December 5, 2013)

MASTER SERVICES AGREEMENT (Filed With SEC on August 6, 2013)

CELLDEX THERAPEUTICS, INC. 2004 EMPLOYEE STOCK PURCHASE PLAN As amended as of March 6, 2013 (Filed With SEC on June 13, 2013)

LEASE between CROWN PERRYVILLE, LLC, as Landlord, and CELLDEX THERAPEUTICS, INC., as Tenant Dated: May 1, 2013 Perryville III at Perryville Corporate Park 53 Frontage Road... (Filed With SEC on May 3, 2013)

12,000,000 Shares Celldex Therapeutics, Inc. Common Stock, $0.001 Par Value per Share UNDERWRITING AGREEMENT (Filed With SEC on February 6, 2013)

EMPLOYMENT AGREEMENT (Filed With SEC on December 21, 2012)

CELLDEX THERAPEUTICS, INC. CONTROLLED EQUITY OFFERINGSM AMENDMENT NO. 1 TO SALES AGREEMENT (Filed With SEC on September 24, 2012)

AMENDMENT TO CELLDEX THERAPEUTICS, INC. 2008 STOCK OPTION AND INCENTIVE PLAN as amended and restated effective as of February 24, 2010 Dated: April 17, 2012 (Filed With SEC on June 14, 2012)

EXECUTION VERSION SECOND LOAN MODIFICATION AGREEMENT (Filed With SEC on March 7, 2012)

10,500,000 Shares Celldex Therapeutics, Inc. Common Stock, $0.001 Par Value per Share UNDERWRITING AGREEMENT (Filed With SEC on February 24, 2012)

MASTER SERVICES AGREEMENT (Filed With SEC on November 3, 2011)

AMENDMENT TO MASTER SERVICES AGREEMENT (Filed With SEC on November 3, 2011)

EMPLOYMENT AGREEMENT (Filed With SEC on July 6, 2011)

10,000,000 Shares Celldex Therapeutics, Inc. Common Stock, $0.001 Par Value per Share UNDERWRITING AGREEMENT (Filed With SEC on May 18, 2011)

JOINDER AND FIRST LOAN MODIFICATION AGREEMENT (Filed With SEC on March 9, 2011)

SECURED PROMISSORY NOTE (Filed With SEC on March 9, 2011)

LOAN AND SECURITY AGREEMENT (Filed With SEC on January 6, 2011)

SECURED PROMISSORY NOTE (Filed With SEC on January 6, 2011)

CELLDEX THERAPEUTICS, INC. 5,000,000 Shares of Common Stock (par value $0.001 per share) Controlled Equity Offeringsm Sales Agreement (Filed With SEC on January 6, 2011)

SEVENTH AMENDMENT TO LEASE (Filed With SEC on August 5, 2010)

CURAGEN CORPORATION AS ISSUER THE BANK OF NEW YORK, AS TRUSTEE UP TO $120,000,000 AGGREGATEPRINCIPAL AMOUNT OF 4.0% CONVERTIBLE SUBORDINATED NOTESDUE 2011 INDENTURE DATED AS OF... (Filed With SEC on March 12, 2010)

COLLABORATION AGREEMENT (Filed With SEC on March 12, 2010)

SECOND RESTATED COLLABORATION AGREEMENT (Filed With SEC on March 12, 2010)

Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. TRANSFER AND TERMINATION AGREEMENT DATED AS OF APRIL... (Filed With SEC on March 12, 2010)

CELLDEXTHERAPEUTICS, INC. 2008 STOCKOPTION AND INCENTIVE PLAN as amendedand restated effective as of February 24, 2010 (Filed With SEC on March 12, 2010)

CELLDEXTHERAPEUTICS, INC. 2004EMPLOYEE STOCK PURCHASE PLAN as amendedand restated effective as of February 24, 2010 (Filed With SEC on March 12, 2010)

CURAGEN CORPORATION 2007 STOCK INCENTIVE PLAN AMENDED and RESTATED (effective May 21, 2008) (Filed With SEC on March 12, 2010)

CELLDEX THERAPEUTICS, INC. RESTRICTED STOCK AWARD AGREEMENT (Filed With SEC on March 12, 2010)

CELLDEXTHERAPEUTICS, INC. INCENTIVESTOCK OPTION AGREEMENT (Filed With SEC on January 25, 2010)

W I T N ES S E T H (Filed With SEC on December 31, 2009)

W I T N ES S E T H (Filed With SEC on October 2, 2009)

RESEARCH COLLABORATION AND COMMERCIALIZATION AGREEMENT (Filed With SEC on March 2, 2009)

Vaccine Adjuvant License and Collaboration Agreement (Filed With SEC on March 2, 2009)

Exclusive Patent And Know-How License Agreement (Filed With SEC on March 2, 2009)

EMPLOYMENTAGREEMENT (Filed With SEC on January 8, 2009)

EMPLOYMENT AGREEMENT (Filed With SEC on January 8, 2009)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on January 8, 2009)

AVANT IMMUNOTHERAPEUTICS, INC. COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on August 11, 2008)

EMPLOYMENT AGREEMENT (Filed With SEC on July 28, 2008)

SEPARATION AND GENERAL RELEASE AGREEMENT (Filed With SEC on July 18, 2008)

Licenseand Development Agreement dated as of April 16, 2008 between Celldex Therapeutics, Inc. and Pfizer Vaccines LLC (Filed With SEC on May 19, 2008)

AGREEMENT AND PLAN OF MERGER BY AND AMONG AVANT IMMUNOTHERAPEUTICS, INC., CALLISTO MERGER CORPORATION AND CELLDEX THERAPEUTICS, INC. Dated as of October 19, 2007 (Filed With SEC on October 23, 2007)

THIRD AMENDMENT TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on October 23, 2007)

AVANTIMMUNOTHERAPEUTICS, INC. 2008 STOCK OPTION AND INCENTIVE PLAN (Filed With SEC on October 23, 2007)

REDACTED COPYCONFIDENTIAL TREATMENT REQUESTED Redacted portions have been marked with brackets containing asterisks([***]). The redacted portions are subject to a request for... (Filed With SEC on May 9, 2007)

FIRST AMENDMENT TO LEASE (Filed With SEC on March 16, 2006)

SECOND AMENDMENT TO LEASE (Filed With SEC on March 16, 2006)

AMENDMENT AGREEMENT TO PURCHASE AGREEMENT (Filed With SEC on March 15, 2006)

CELLDEXTHERAPEUTICS, INC. (aDelaware corporation) SHARESOF COMMON STOCK (parvalue $0.01 per share) PURCHASEAGREEMENT (Filed With SEC on June 8, 2005)

AMENDMENT NO. 1 TO ASSET PURCHASE AGREEMENT (Filed With SEC on June 8, 2005)

CELLDEX THERAPEUTICS,INC. 2005EQUITY INCENTIVE PLAN (Filed With SEC on June 8, 2005)

MABVAC , INC. EMPLOYEESTOCK PURCHASE PLAN (Filed With SEC on June 8, 2005)

PURCHASEAGREEMENT Dated as ofMay 16, 2005 between AVANTIMMUNOTHERAPEUTICS, INC. and PRF VACCINEHOLDINGS LLC (Filed With SEC on May 18, 2005)

SupplementalConditions of the Standard Form of Agreement Between Owner and Design/Builder between AVANT Immunotherapeutics, Inc. (Owner) and SPECProcess Engineering &... (Filed With SEC on November 9, 2004)

ASSIGNMENTAND LICENSE AGREEMENT (Filed With SEC on September 22, 2004)

RESEARCH AND COMMERCIALIZATION AGREEMENT (Filed With SEC on September 22, 2004)

ASSIGNMENTAND LICENSE AGREEMENT (Filed With SEC on August 16, 2004)

RESEARCH AND COMMERCIALIZATION AGREEMENT (Filed With SEC on August 16, 2004)

Confidential Treatment Requested As ToCertain Information Contained In This Exhibit LEASE from MASSACHUSETTS DEVELOPMENT FINANCE AGENCY, Landlord to AVANT IMMUNOTHERAPEUTICS, INC.... (Filed With SEC on April 30, 2004)

ConfidentialTreatment Requested As To Certain Information Contained In This Exhibit SECURITY AGREEMENT: EQUIPMENT (Dated andeffective as of December 22, 2003) (Filed With SEC on April 30, 2004)

ConfidentialTreatment Requested As To Certain Information Contained In This Exhibit SECURED PROMISSORY NOTE: EQUIPMENT LOAN SUMMARY OF TERMS ANDDEFINITIONS (Filed With SEC on April 30, 2004)

Confidential Treatment Requested As To Certain Information Contained InThis Exhibit NON-EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on April 30, 2004)

Subcontractor Service Agreement No. DPSC02-02257 (Filed With SEC on November 6, 2003)

SUBCONTRACT MODIFICATION (Filed With SEC on November 6, 2003)

Subcontractor Service Agreement No. DPSC03-02246 (Filed With SEC on November 6, 2003)

SECOND AMENDMENT TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on November 6, 2003)

RESTRICTED STOCK UNITAGREEMENT UNDER THE AVANT IMMUNOTHERAPEUTICS, INC. 1999 STOCK OPTION AND INCENTIVE PLAN (Filed With SEC on November 6, 2003)

Category

Industry

Companies

Contracts

Celldex Therapeutics, Inc. Contracts & Agreements